Laboratorios Farmaceuticos Rovi, S.A.

OTC
LABFF
paper.types.company
Rentabilité sur six mois: 0%
Rendement en dividendes: 3.82%
Secteur: Healthcare

Calendrier des promotions Laboratorios Farmaceuticos Rovi, S.A.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Laboratorios Farmaceuticos Rovi, S.A.

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It provides non-prescription pharmaceutical products; and contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, hard capsules, and sachets. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
2.72
Дивиденд ао
0.8616
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 5.84 2
P/BV 7.68 1
P/E 32.61 5
Efficacité
Nom Signification Grade
ROA 17.6 5
ROE 25.83 8
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 3.82 9.55
DSI 0.9 9
Croissance moyenne du dividende -48.51 0
Devoir
Nom Signification Grade
Debt/EBITDA 0.5511 9
Debt/Ratio 0.1376 10
Debt/Equity 0.4307 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 133.61 10
Rentabilité Ebitda, % 175.76 10
Rentabilité EPS, % 210.9 10
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 90.61 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 90.61 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 90.61 $ 90.61 $ 90.61 $ 0 % 0 % 0 %
common.calendar.number_days.90d 90.61 $ 90.61 $ 90.61 $ 0 % 0 % 0 %
common.calendar.number_days.180d 90.61 $ 90.61 $ 90.61 $ 0 % 0 % 0 %
common.calendar.number_days.1y 90.61 $ 90.61 $ 90.61 $ 0 % 0 % 0 %
common.calendar.number_days.3y 51.1 $ 0.03 $ 90.61 $ 77.32 % 0 % 0 %
common.calendar.number_days.5y 0.03 $ 0.03 $ 90.61 $ 302033.34 % 0 % 0 %
common.calendar.number_days.10y 0.03 $ 0.03 $ 90.61 $ 302033.34 % 0 % 0 %
common.calendar.number_days.ytd 90.61 $ 90.61 $ 90.61 $ 0 % 0 % 0 %

Principaux propriétaires

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Juan Lopez-Belmonte Encina Chairman & CEO 1.25M
Mr. Ivan Lopez-Belmonte Encina Second Deputy Chairman & GM of Commercial and Development 505.46k
Mr. Javier Lopez-Belmonte Encina First Deputy Chairman, GM of Industrial Operations & CFO 507.61k
Marta Campos Martínez Head of Investor Relations N/A
Ms. Mercedes Benítez del Castillo Sánchez Legal Department Manager N/A
Ms. Rosario Perucha Pérez Marketing Manager N/A
Mr. Francisco Javier Angulo García Human Resources Manager N/A
Mr. Gabriel Nunez Fernandez Secretary N/A
Ms. Beatriz Ávila Alcalde Sales Manager N/A

Informations sur l'entreprise

Adresse: Spain, Madrid, Calle José Isbert. 2 - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.rovi.es